Something is quietly shifting in Maryland’s industrial landscape. After decades of outsourcing, manufacturing is showing signs of coming home, and precision technology is at the center of this ...
The "Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century--A Risk Based Approach" initiative was ...
The demands of developing new biologic modalities like bispecific antibodies are pushing the limits of traditional drug manufacturing. For the modern biomanufacturer, process intensification is ...
That's right folks: buckle up, because we're well into the bumpy roads of sub-nanometer steps in fabrication process improvements. Intel's about to start launching chips fabbed on its 18A process ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback